Modulation of single-nephron GFR in the db/db mouse model of type 2 diabetes mellitus. II. Effects of renal mass reduction (American Journal of Physiology - Regulatory Integrative and Comparative Physiology (2008) 294, (R1840-R1846) doi:10.1152/ajpregu.00457.2007);Modulation of single-nephron GFR in the db/db mouse model of type 2 diabetes mellitus. II. Effects of renal mass reduction

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 294, Issue 6, 2008, Pages

  Levine, David Z ^a,b   Iacovitti, Michelle ^a   Robertson, Susan J ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

^b OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

Author keywords

Hyperfiltration; Neuronal nitric oxide synthase; Tubuloglomerular feedback

Indexed keywords

NEURONAL NITRIC OXIDE SYNTHASE; S METHYLTHIOCITRULLINE; NOS1 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DISEASE COURSE; GLOMERULUS; GLOMERULUS FILTRATION RATE; HISTOPATHOLOGY; HYPERGLYCEMIA; KIDNEY FUNCTION; KIDNEY TUBULE; MOUSE; NEPHRECTOMY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PRIORITY JOURNAL; ANIMAL; C57BL MOUSE; DISEASE MODEL; DRUG ANTAGONISM; FEEDBACK SYSTEM; KIDNEY; KIDNEY PROXIMAL TUBULE; NEPHRON; ORGAN SIZE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; FEEDBACK; GLOMERULAR FILTRATION RATE; KIDNEY; KIDNEY TUBULES, PROXIMAL; MICE; MICE, INBRED C57BL; NEPHRECTOMY; NEPHRONS; NITRIC OXIDE SYNTHASE TYPE I; ORGAN SIZE;

EID: 47549101840     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.zh6-6639-corr.2009     Document Type: Erratum

References (37)

1. Anderson S, Brenner BM. Role of altered capillary hemodynamics in the initiation and progression of diabetic microangiopathy. J Diabetes Complications 2: 59-61, 1988.
2. Arima S, Ito S. The mechanisms underlying altered vascular resistance of glomerular afferent and efferent arterioles in diabetic nephropathy. Nephrol Dial Transplant 18: 1966-1969, 2003.
3. Bak M, Thomsen K, Christiansen T, Flyvbjerg A. Renal enlargement precedes renal hyperfiltration in early experimental diabetes in rats. J Am Soc Nephrol 11: 1287-1292, 2000.
4. Blantz RC, Gabbai FB, Peterson OW, Thomson SC. Tubuloglomerular feedback activity after acute reductions in renal mass. Kidney Int Suppl 32: S102-S105, 1991.
5. Blantz RC, Peterson OW, Gushwa L, Tucker BJ. Effect of modest hyperglycemia on tubuloglomerular feedback activity. Kidney Int Suppl 12: S206-S212, 1982.
6. Bower G, Brown DM, Steffes MW, Vernier RL, Mauer SM. Studies of the glomerular mesangium and the juxtaglomerular apparatus in the genetically diabetic mouse. Lab Invest 43: 333-341, 1980.
7. Brenner BM, Anderson S. Glomerular function in diabetes mellitus. Adv Nephrol Necker Hosp 19: 135-144, 1990.
8. Brenner BM, Hostetter TH, Olson JL, Rennke HG, Venkatachalam MA. The role of glomerular hyperfiltration in the initiation and progression of diabetic nephropathy. Acta Endocrinol 242: 7-10, 1981.
9. Bush MA, Pollack GM. Pharmacokinetics and protein binding of the selective neuronal nitric oxide synthase inhibitor 7-nitroindazole. Biopharm Drug Dispos 21: 221-228, 2000.
10. Erdely A, Freshour G, Maddox DA, Olson JL, Samsell L, Baylis C. Renal disease in rats with type 2 diabetes is associated with decreased renal nitric oxide production. Diabetologia 47: 1672-1676, 2004.
11. Fattor RA, Silva FG, Eigenbrodt EH, D'Agati V, Seney F. Effect of unilateral nephrectomy on three patients with histopathological evidence of diabetic glomerulosclerosis in the resected kidney. J Diabetes Complications 1: 107-113, 1987.
12. Gartner K. Glomerular hyperfiltration during the onset of diabetes mellitus in two strains of diabetic mice (c57bl/6j db/db and c57bl/ksj db/db). Diabetologia 15: 59-63, 1978.
13. +/glucose cotransporter activity in renal proximal tubule cells. Am J Physiol Renal Physiol 288: F988-F996, 2005.
14. Hayashi K, Epstein M, Loutzenhiser R, Forster H. Impaired myogenic responsiveness of the afferent arteriole in streptozotocin-induced diabetic rats: role of eicosanoid derangements. J Am Soc Nephrol 2: 1578-1586, 1992.
15. Hostetter TH, Olson JL, Rennke HG, Venkatachalam MA, Brenner BM. Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation. J Am Soc Nephrol 12: 1315-1325, 2001.
16. Komers R, Lindsley JN, Oyama TT, Anderson S. Effects of long-term inhibition of neuronal nitric oxide synthase (NOS1) in uninephrectomized diabetic rats. Nitric Oxide 11: 147-155, 2004.
17. Levine DZ. Can rodent models of diabetic kidney disease clarify the significance of early hyperfiltration? Recognizing clinical and experimental uncertainties. Clin Sci (Lond) 114: 109-118, 2008.
18. Levine DZ. Hyperfiltration, nitric oxide, and diabetic nephropathy. Curr Hypertens Rep 8: 153-157, 2006.
19. Levine DZ, Iacovitti M. Real time microelectrode measurement of nitric oxide in kidney tubular fluid in vivo. Sensors 3: 314-320, 2003.
20. Levine DZ, Iacovitti M, Burns KD, Zhang X. Real-time profiling of kidney tubular fluid nitric oxide concentrations in vivo. Am J Physiol Renal Physiol 281: F189-F194, 2001.
21. Levine DZ, Iacovitti M, Robertson SJ, Mokhtar GA. Modulation of single-nephron GFR in the db/db mouse model of type 2 diabetes mellitus. Am J Physiol Regul Integr Comp Physiol 290: R975-R981, 2006.
22. Lorenz JN, Schultheis PJ, Traynor T, Shull GE, Schnermann J. Micropuncture analysis of single-nephron function in NHE3-deficient mice. Am J Physiol Renal Physiol 277: F447-F453, 1999.
23. O'Donnell MP, Kasiske BL, Daniels FX, Keane WF. Effects of nephron loss on glomerular hemodynamics and morphology in diabetic rats. Diabetes 35: 1011-1015, 1986.
24. Ohishi K, Okwueze MI, Vari RC, Carmines PK. Juxtamedullary microvascular dysfunction during the hyperfiltration stage of diabetes mellitus. Am J Physiol Renal Fluid Electrolyte Physiol 267: F99-F105, 1994.
25. Ollerstam A, Pittner J, Persson AE, Thorup C. Increased blood pressure in rats after long-term inhibition of the neuronal isoform of nitric oxide synthase. J Clin Invest 99: 2212-2218, 1997.
26. Parving HH, Mauer M, Ritz E. The Kidney (7th ed.). New York: Saunders, 2004.
27. Pollock CA, Lawrence JR, Field MJ. Tubuloglomerular feedback in renal hypertrophy. Kidney Int Suppl 32: S106-S109, 1991.
28. Schnermann J. Micropuncture analysis of tubuloglomerular feedback regulation in transgenic mice. J Am Soc Nephrol 10: 2614-2619, 1999.
29. Schnermann J, Levine DZ. Paracrine factors in tubuloglomerular feedback: adenosine, ATP, and nitric oxide. Annu Rev Physiol 65: 501-529, 2003.
30. Szabo AJ, Wagner L, Erdely A, Lau K, Baylis C. Renal neuronal nitric oxide synthase protein expression as a marker of renal injury. Kidney Int 64: 1765-1771, 2003.
31. Thomson SC, Deng A, Bao D, Satriano J, Blantz RC, Vallon V. Ornithine decarboxylase, kidney size, and the tubular hypothesis of glomerular hyperfiltration in experimental diabetes. J Clin Invest 107: 217-224, 2001.
32. Thomson SC, Vallon V, Blantz RC. Kidney function in early diabetes: the tubular hypothesis of glomerular filtration. Am J Physiol Renal Physiol 286: F8-F15, 2004.
33. US Renal Data System. USRDS 2006 Annual Data Report. Bethesda, MD: National Institute of Diabetes and Digestive and Kidney Diseases, 2007.
34. Vallon V, Blantz RC, Thomson S. Homeostatic efficiency of tubuloglomerular feedback is reduced in established diabetes mellitus in rats. Am J Physiol Renal Fluid Electrolyte Physiol 269: F876-F883, 1995.
35. Vallon V, Traynor T, Barajas L, Huang YG, Briggs JP, Schnermann J. Feedback control of glomerular vascular tone in neuronal nitric oxide synthase knockout mice. J Am Soc Nephrol 12: 1599-1606, 2001.
36. Wesson DE. Moving closer to an understanding of the hyperfiltration of type 2 diabetes mellitus. Am J Physiol Regul Integr Comp Physiol 290: R973-R974, 2006.
37. Zatz R, Dunn BR, Meyer TW, Anderson S, Rennke HG, Brenner BM. Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest 77: 1925-1930, 1986.